| Particulars |
|
|
|
| Company Name
| ERIS Lifesciences Ltd
| Year End
| 202603
|
| Full Year |
| Equity (₹ Cr.) |
13.86 |
B.V. (₹) |
230.60 |
| Sales(₹ Cr.) |
1,779.77 |
NP (₹ Cr.) |
253.94 |
| NP Var% |
234.00 |
Div% |
721.00 |
| CPS(₹) |
29.50 |
EPS (₹) |
18.30 |
| Traded Value(₹ Lakhs) |
9,951.99 |
52 Week High |
1,819.00 |
| 52 Week Low |
1,238.00 |
Price BSE |
1,393.00 |
| Price NSE |
1,390.00 |
Market Capital (₹ Cr.) |
19,309.50 |
| P/C Ratio |
47.30 |
P/E Ratio |
76.00 |
| Price Vs.BV |
6.04 |
|
| Latest Quarter |
| Year End |
202606 |
Sales (₹ Cr.) |
433.81 |
| NP(₹ Cr.) |
48.30 |
NP Var % |
-52.00 |
| Trailing Twelve Months |
| Year End |
202606 |
Sales |
1,526.13 |
| OPM |
28.47 |
NP |
116.31 |
| NP Var% |
28.62 |
EPS |
14.88 |
| PE |
93.64 |
|
|